Accolade Inc
NASDAQ:ACCD
Accolade Inc
Total Receivables
Accolade Inc
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
Total Receivables
$26.7m
|
CAGR 3-Years
181%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Total Receivables
$3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Receivables
$1.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Total Receivables
$32.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Cigna Corp
NYSE:CI
|
Total Receivables
$20.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Receivables
$2.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
See Also
What is Accolade Inc's Total Receivables?
Total Receivables
26.7m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Total Receivables amounts to 26.7m USD.
What is Accolade Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
31%
Over the last year, the Total Receivables growth was -13%. The average annual Total Receivables growth rates for Accolade Inc have been 181% over the past three years , 31% over the past five years .